Drug Kinetics – Products

Aptamer validates targeted RNA delivery to liver fibrosis cells using its Optimer platform and a novel HSC marker.

Nicoya acquires Applied Photophysics, boosting biopharma capabilities with advanced analytical tools for protein-based drug discovery.

DEBRA Research and Dermaliq partner to advance cutaneous drug delivery for improved wound healing and therapies in EB.

SCIEX unveils new software enhancements at ASMS 2025, featuring SCIEX OS 4.0 and AI-driven data automation for faster, more accurate results.

CN Bio partners with SCINCO to expand its reach in South Korea, enhancing access to its FDA-recognized PhysioMimix® Organ-on-a-chip systems.

Aptamer licenses Optimers to the University of Glasgow for use in swine vaccines, targeting global animal health markets.

CN Bio and Pharmaron have partnered to validate PhysioMimix® OOC technology, aiming to improve drug discovery and development through human-relevant models.

Cyprumed and MSD have partnered to develop oral peptide formulations using Cyprumed’s drug delivery technology.

This app note highlights the advantages of electron-activated dissociation (EAD) in identifying oxidative metabolites of the molecular glue, mezigdomide.

BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer virtual access for worldwide attendees.